No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.

Schernthaner, G-H; Plank, C; Minar, E; Bieglmayer, C; Koppensteiner, R; Schernthaner, G

Schernthaner, G-H; Plank, C; Minar, E; Bieglmayer, C; Koppensteiner, R; Schernthaner, G.

Affiliation

Schernthaner GH; Department of Internal Medicine II, Medical University of Vienna, and Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria. gerit.schernthaner@meduniwien.ac.at

Eur J Clin Invest ; 36(5): 333-9, 2006 May.

Article in En | MEDLINE | ID: mdl-16634837

Subject(s)

Arterial Occlusive Diseases/etiology; Hyperhomocysteinemia/drug therapy; Peripheral Vascular Diseases/etiology; Vasculitis/drug therapy; Aged; Arterial Occlusive Diseases/blood; Biomarkers/blood; Chronic Disease; Drug Therapy, Combination; Female; Folic Acid/therapeutic use; Hemostasis/drug effects; Homocysteine/blood; Humans; Hyperhomocysteinemia/complications; Inflammation Mediators/blood; Male; Middle Aged; Patient Compliance; Peripheral Vascular Diseases/blood; Vasculitis/blood; Vasculitis/etiology; Vitamin B Complex/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arterial Occlusive Diseases / Vasculitis / Peripheral Vascular Diseases / Hyperhomocysteinemia Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Invest Year: 2006 Document type: Article Affiliation country: Austria Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links